DR. DAVID C. KLONOFF, M.D.
Osteopathic Medicine in Burlingame, CA

License number
California G35726
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G35726
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1720 El Camino Real Suite #130, Burlingame, CA 94010
Phone
(650) 697-4345
(650) 259-5840 (Fax)

Organization information

See more information about DAVID C. KLONOFF at bizstanding.com

DAVID C. KLONOFF, M.D., INC

1720 El Camino Real, Burlingame, CA 94010

Doing business as:
David C Klonoff MD
Registration:
Dec 21, 2001
Phone:
(650) 697-4345 (Phone)
State ID:
C2402354
Business type:
Articles of Incorporation
President:
David C. Klonoff (President)
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Physicians & Surgeons
Products:
Endocrinology

Professional information

David C Klonoff Photo 1

Dr. David C Klonoff, Burlingame CA - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
1720 El Camino Real, Burlingame 94010
(650) 697-4345 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1981, Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English, German, Hebrew
Education:
Medical School
University Of California, San Francisco, School Of Medicine
Graduated: 1976
University Of California
University Of California San Francisco Hospitals & Clinics


David Charles Klonoff Photo 2

David Charles Klonoff, Burlingame CA

Specialties:
Internist
Address:
1720 El Camino Real, Burlingame, CA 94010
Education:
University of California San Francisco, School of Medicine - Doctor of Medicine
University of California, San Francisco - Medical Center - Residency - Internal Medicine
Ronald Reagan UCLA Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)


David Klonoff Photo 3

Method And Apparatus For Improving The Accuracy Of Alternative Site Analyte Concentration Measurements

US Patent:
2003017, Sep 18, 2003
Filed:
Nov 21, 2002
Appl. No.:
10/302071
Inventors:
Peter Rule - Los Altos Hills CA, US
James Braig - Piedmont CA, US
Phillip Hartstein - Cupertino CA, US
Heidi Smith - Union City CA, US
David Klonoff - Burlingame CA, US
International Classification:
G01N033/53, G06F019/00, G01N033/48, G01N033/50
US Classification:
435/007100, 702/019000
Abstract:
Methods and apparatuses for improving the accuracy of analyte concentration measurements at alternative sites and information provided to the user. The present invention advantageously utilizes information relating to the rate of change of analyte concentrations to adjust analyte concentrations measurements and/or information provided to the user. Therefore, the present invention provides new and improved methods and apparatuses for obtaining analyte concentration information at physiological sites other than the fingertips while ensuring that the analyte concentration information accurately reflects systemic analyte concentration values.


David Klonoff Photo 4

Reagent-Less Whole-Blood Glucose Meter

US Patent:
2003009, May 15, 2003
Filed:
Jan 21, 2002
Appl. No.:
10/055875
Inventors:
Bernhard Sterling - Sunnyvale CA, US
Philip Hartstein - Cupertino CA, US
Kenneth Li - Piedmont CA, US
Mark Agostino - Alameda CA, US
David Klonoff - Burlingame CA, US
Robert Gaffney - Atherton CA, US
Peng Zheng - Alameda CA, US
Jennifer Gable - Walnut Creek CA, US
Kenneth Witte - San Jose CA, US
Heidi Smith - Union City CA, US
Jane Sheill - Fremont CA, US
Mike Munrow - Belmont CA, US
W. Hall - Oakland CA, US
Daniel Goldberger - Boulder CO, US
Martin Fennell - Fairfield CA, US
Julian Cortella - Alameda CA, US
James Braig - Piedmont CA, US
Peter Rule - Los Altos Hills CA, US
International Classification:
G01N033/48
US Classification:
356/039000
Abstract:
A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.